Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. [electronic resource]
Producer: 20180220Description: 1671-1679 p. digitalISSN:- 1879-114X
- Adolescent
- Adult
- Delayed-Action Preparations -- adverse effects
- Dimethyl Fumarate -- adverse effects
- Female
- Glatiramer Acetate -- therapeutic use
- Humans
- Immunosuppressive Agents -- adverse effects
- Interferon-beta -- therapeutic use
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Recurrence
- Risk Assessment
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.